Frank Ntilikina

GG
Partizan Mozzart Bet Belgrade
In uniform for Round 18
GPartizan Mozzart Bet Belgrade
December 27, 2024
Ntilikina (groin/illness) will be available for Friday's game against ASVEL, according to Mozzart Sport.
ANALYSIS
An ailment and an injury cost Ntilikina two weeks of action, but he has recovered from both and is ready to return to the court.
Read More News
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
EuroLeague Total Stats
Loading Total Stats...
EuroLeague Per 36 Stats
Loading Per 36 Stats...
2024
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
Advanced Stats
Loading Advanced Stats...
Partizan Mozzart Bet Belgrade Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Could play Friday
GPartizan Mozzart Bet Belgrade
Groin
December 26, 2024
Ntilikina (groin) could play Friday against Fenerbahce, according to Meridian Sport.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Will miss another Round
GPartizan Mozzart Bet Belgrade
Groin
December 19, 2024
Ntilikina (groin/illness) will not play Friday against Efes, according to Meridian Sport.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Absent for Round 16
GPartizan Mozzart Bet Belgrade
Groin
December 17, 2024
Ntilikina (groin/illness) will not play Tuesday against ASVEL, according to Meridian Sport.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Unable to play Sunday
GPartizan Mozzart Bet Belgrade
Groin
December 15, 2024
Ntilikina did not play in Sunday's domestic contest due to a groin injury and an illness, according to Mozzart Sport.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Scores season-high 15 points
GPartizan Mozzart Bet Belgrade
December 3, 2024
Ntilikina delivered 15 points, five rebounds, three assists, two steals and three three-pointers in Tuesday's win over Zalgiris.
ANALYSIS
Subscribe now to instantly reveal our take on this news.